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The prominence of thrombosis in the pathogenesis of the Arthns phenomenon 
(1, 2), the alterations in the clotting mechanism seen in experimental anaphy- 
laxis (3),  and the occurrence of "fibrinoid"  in lesions generally considered to 
be due  to hypersensitivity suggest that  the  interaction of  antigen and anti- 
body in vivo may in some manner initiate coagulation. Experiments to be re- 
ported here indicate that such an effect can, in fact,  be demonstrated in vitro 
under appropriate conditions. Although the  mechanism of  this phenomenon 
is not yet clear, it seems worth while to report the basic observations because 
of their apparent pertinence to various irnmunopathological problems. 
Materials and Methods 
Antigens.--The antigens used were ovalbumin (2X crystallized, obtained from Worthing- 
ton Biochemical Corp.), bovine gamma globulin and bovine serum albumin (obtained from 
Armour Laboratories), native dextran  (kindly supplied by Dr. E. Hehre), and preparations 
of the somatic antigen ('qlpopolysaccharide endotoxin")  of Escheri~hia eoli strain 0111  :B4 
(obtained from Difco Laboratories, Inc., Detroit). Rabbits were immunized against nvalbumin 
or the bovine proteins by repeated intradermal  and/or intravenous injections of antigen in 
doses which ranged from i  to 50 rag. Serum obtained from immunized and normal animals 
was stored in the frozen state and allquots were inactivated  by heating at 56°C. for a half- 
hour before use. 
Coagulation Time Measurement.--Whole blood was obtained from normal and immunized 
rabbits by cardiac puncture and immediately distributed in 2.0 or 4.0 ml. amounts in 15 x 75 
mm. siliconized glass test tubes. The tubes were kept at room temperature,  and the end- 
point of coagulation was taken as that time at which no flow occurred upon inversion of the 
tube. The effect of various test materials on the coagulation time was determined by adding 
these materials in a total volume of 0.1 or 0.2 ml. to the tubes before addition of the blood. 
Under these conditions the coagulation time of rabbit blood was usually prolonged to from 
20 to 40 minutes as compared to 8 to 12 minutes in clean but non-siliconized  glassware. This 
prolongation of clotting time permitted  an evaluation of the coagulation-accelerating effect 
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of various added test materials. In a few experiments the coagulation  time was prolonged by 
other methods as well, such as by the addition of small amounts of heparin or by carrying 
out the determinations in the cold, but all of the experiments  reported here were done with 
siliconized glassware as described above. 
TABLE I 
Effect~ BoW~ Gamma Globulin ~  Blood ~  Normd and lmmuneRabb~s 
Source ot blood 
Normal rabbits 
Rabbit  No. 
Average 
immunized rabbits 
~verage 
0 (NaC1) 
m~n. 
42 
34 
34 
25 
33.7 
25 
18 
3O 
18 
30 
18 
29 
24.0 
Coagulation  time 
Concentration  of BGG ~g./ml.) 
50  0.05 
44 
37 
33 
25 
34.7 
25 
12 
19 
14 
25 
20 
21 
19.4 
0.5 
m~n. 
45 
37 
38 
25 
I 
36.3 
25 
12 
20 
11 
20 
14 
25 
18.4 
5.0 
42 
40 
38 
25 
36.3 
22 
12 
17 
11 
18 
12 
17 
15.6 
,n/n. 
43 
40 
35 
24 
35.5 
17 
Ii 
16 
5 
17 
ii 
18 
13.6 
Each tube  contained 0.I  ml.  antigen  dilution  or  physiological  saline  solution,  to  which was 
added 2.0  ml. whole blood.  Concentrations of  BGG  are  expressed as the final  concentration 
in  the  clotting  mixture.  Variations  in  thc  control-clotting  time  from  rabbit  to  rabbit  appeared 
to be related  to the care and dispatch with which cardiac  puncture and distribution  of the 
blood was accomplished. The data  illustrate  the  consistent  coagulation-accelerating  effect  of 
BGG  on the  blood  of  specifically  immunized rabbits. 
EXPERIMENTAL 
Effect of Addition  of Antigen  to Blood  of Immunized  Rabbits.--It  had  been 
observed earlier (4) that the addition of ovalbumin in vitro to whole blood from 
immunized  rabbits resulted  in  the  prompt  and  striking  agglutination of  the 
platelets and leucocytes in the preparation. In the present study it was found 
that, in the absence of anticoagulants, such preparations clot in a much shorter 
time than do the appropriate control preparations. The results of experiments 
with  ovalbumin,  bovine  serum  albumin  (BSA),  and  bovine  gamma  globulin 
(BGG)  were  quite  comparable,  and  are  illustrated in  Table I.  The  addition 
of  these  antigens  did not  appreciably affect  the  coagulation time  of  normal 
rabbit blood but  produced marked  and  reproducible acceleration of  clotting J'.  ROBBINS  AND  C. A.  STETSON 
of  blood  samples  from  specifically immunized rabbits.  This  effect  was  ob- 
served  over  a  wide  range of  antigen concentrations, with  amounts of BGG 
as little as 0.05/~g./ml. blood being sufficient to produce significant depression 
of the clotting time. An attempt was made to correlate the concentration of 
antigen required to  produce platelet clumping with  that  necessary to  cause 
TABLE II 
Effect of Mixtures of Bovine Gamma Globulin and Normal or Immune Serum on the Coagulation 
Time of Normal Rabbit Blood 
Serum added 
Normal rabbit serum 
Antiovalbumin  serum 
Anti-BGG  serum 
Rabbit No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Coagulation time 
Concentration of BGG (#g.lmL) 
o (Nat1) 
raift. 
36 
34 
21 
21 
18 
20 
33 
20 
21 
35 
26 
24 
33 
35 
30 
0.005  ).05 
rain.  ~in. 
--  33 
--  19 
--  18 
--  20 
~  23 
--  13 
16  13 
25  17 
12  11 
13  11 
26  20 
27  27 
20  17 
0.5  5.0 
rain.  rai#. 
36  35 
33  36 
24  22 
18  20 
16  18 
21  18 
16  20 
8  13 
10 
12 
8  -- 
8  -- 
20  15 
2O  18 
14  14 
5O 
32 
27 
19 
20 
16 
18 
16 
10 
14 
22 
13 
Each tube contained 0.05 ml. antigen dilution and 0.05 ml. undiluted inactivated serum 
mixed together immediately before addition of 2.0 ml. whole blood from normal rabbits. The 
rabbit numbers refer to the normal donors of whole blood used as the dotting system in each 
series of determinations. Mixtures of BGG with normal rabbit serum or rabbit antiovalbumin 
serum were without effect, while the mixtures of BGG with anti-BGG serum consistently 
produced significant shortening of the coagulation time. 
accelerated  coagulation, but the  spontaneous slow agglutination of platelets 
in control preparations made it impossible to  accurately determine an end- 
point in antigen fitrations. 
Effect  of Antigen-Antibody  Mixtures  on  Normal  Rabbit  Blood.--In  order to 
determine whether the observed effect was mediated by serum antibody, small 
amounts of  serum from  the  immunized rabbits were  mixed with  antigen in 
v#ro  and whole  blood from  normal rabbits was  then  added  as  an indicator IMMUNE  REACTIONS  AND  BLOOD  COAGULATION 
system.  Table II shows  the  results  of  a  typical  experiment with  BGG and 
anti-BGG serum, and it can be seen that the antigen-antibody mixture pro- 
duced  a  considerable  coagulation-accelerating  effect.  This  system permitted 
the  titration  of antiserum as well as antigen,  and Table III shows that  the 
phenomenon was demonstrable over a wide range of dilution of antiserum and 
of concentration of antigen. 
In some experiments there was a  suggestion of a  prozone; for example, the 
data in Table III suggest that a concentration of BGG of 5 gg./ml, was more 
TABLE  III 
Titration of Anti-Bovine Gamma Globulin Serum 
Concentration of BGG 
~g./mL 
50 
5.0 
0.5 
0.05 
0 (NaCl) 
No. of rabbits 
Coagulation time 
Dilution of antiserum 
NaC1 
1/2550  1/40  1/80 
rain.  mln. 
16.0  15.7 
11.3  12.3 
14.0  15.0 
25.0  28.0 
25.3  24.8 
l/t60  1/640 
rain.  rain. 
15.4  20.3 
11.7  12.3 
15.5  17.5 
29.0  29.0 
23.0  21.0 
m~n. 
23.7 
19.0 
18.0 
27.0 
24.0 
m~n. 
28.7 
28.7 
26.0 
31.5 
24.2 
Each tube contained 0.05 ml. antigen and 0.05 ml. antibody, as in Table H. The concen- 
trations are expressed as final concentrations in the clotting mixture, after addition of 2.0 
ml. normal rabbit blood. The coagulation times shown are the averages of determinations per- 
formed with either two or three normal blood donors, as shown. Even the highest dilution of 
serum tested showed some activity. 
effective than  50 gg./ml.  The investigation  of  still  higher  concentrations  of 
antigen was prevented by the tendency of BGG to show non-specific coagu- 
lation-accelerating effects at concentrations of 500 Izg./ml. or higher.  Neither 
this  latter  effect nor  a  prozone  was  seen  in  experiments with  high  concen- 
trations of ovalbumin. 
Effect  of Reaction  of Antigens with Natural Antibodies.--The  sera of many 
supposedly  normal  animals  contain  antibodies  which  give  cross-precipitin 
reactions with glycogen and other polyglucoses of similar structure (5). Native 
dextran has been shown to give such reactions with normal rabbit sera  (6), 
and it was of interest to find that the addition of this polysaccharide antigen 
to the whole blood of normal rabbits produced an acceleration of clotting like 
that  described  above  with  protein  antigen-antibody  systems  (Table  IV). 
Natural antibodies to the somatic antigens of E. coli also exist in normal rabbit 
sera, as judged by the occurrence of weak but definite precipitin reactions which 
promptly become stronger following specific immunization  (7).  It was found J.  ROBBINS  AND  C.  A.  STETSON 
that  the  addition  of E.  coli  lipopolysaccharide  to  normal  rabbit  blood  also 
accelerated coagulation  (Table IV). In order to determine whether this effect 
was  due  to  the  antigenic  or  to  the  "endotoxic"  properties  of this  bacterial 
antigen,  rabbits were made tolerant  to it  by the daily intravenous injection 
of increasing  doses for  10  days.  The  animals  were  then  bled and  the  blood 
was tested with endotoxin  in  vitro.  It was reasoned  that  if the coagulation- 
accelerating  effect  of  E.  coli  lipopolysaccharide  were  due  to  the  endotoxic 
properties  of this  material,  the  blood from the  tolerant  animals  should  not 
TABLE IV 
Effect of Dextran and Endotoxin  on Rabbit Blood and Plasma 
Clotting system 
~ormal blood 
ormal blood 
:Tolerant" blood 
{ormal plasma 
{ormal plasma 
Coagulation time 
No. of  Antigen concentration  Antigen added  rabbits 
Native dextran 
E. coli endotoxin 
E. coli endotoxin 
Native dextran 
E. coli endotoxin 
0 
(NaC1) 
rain. 
32.8 
37.3 
40.6 
19.3 
21.5 
0.01 
mln. 
29.8 
36.8 
39.8 
18.3 
(m./ml.) 
0.1  1.0  10 
rain.  rain.  rain. 
25.2  21.2  20.2 
35.0  27.5  23.8 
36.2  29.2  16.8 
16.7  16.7  16.7 
--  20.5  20.3 
100 
19.C 
19A 
12.2 
20.7 
Each tube contained 0.1 ml. antigen and 2.0 ml. whole blood or 0.i ml. antigen and 2.0 
ml. plasma. The antigen concentrations are the final concentrations in the clotting system, 
and  the  coagulation times are averages of multiple determinations, each performed with 
blood or plasma from an individual rabbit. There was no significant effect when dextran or 
endotoxin was added to plasma, but both of these substances shortened the coagulation time 
of normal blood and the E. coli endotoxin had at least an equal effect on the blood of "toler- 
ant" rabbits. 
exhibit this effect. If, on the other hand,  the effect were due to the reaction 
of the E.  coli  antigen with natural  antibodies,  the blood of tolerant  animals 
might be expected to react even more than  that  of controls,  because of the 
increased antibody levels known to be present  (8).  As may be seen in Table 
IV, the results of this experiment were more in accord with  the latter inter- 
pretation. 
McKay  et  al.  (9)  have recently reported  a  coagulation-accelerating  effect 
of other endotoxins on human blood, and it has been found in this laboratory 
that native dextran produces a  similar effect on normal human blood.  These 
observations suggest that the phenomenon under study is not peculiar to the 
rabbit, and experiments with immunized laboratory animals of various species 
are under way to determine whether it is of general occurrence. 
Data  obtained  by McKay et  al.  suggest  that  the  coagulation-accelerating 
effect of endotoxins  on  human  blood might  be mediated  by platelets,  since IMMUNE  REACTIONS  AND  BLOOD  COAGULATION 
the effect of endotoxin on "platelet-poor"  plasma was considerably less marked 
than  on  "platelet-rich"  plasma.  The  testing  of this  point  was  considerably 
facilitated in our experiments by the tendency of rabbit platelets to aggluti- 
nate spontaneously (4),  so that centrifugation of whole blood at 0°C.  for 15 
minutes  at  4,000  times  gravity  yielded  preparations  of  plasma  that  were 
virtually platelet-free. As shown in Table IV, the clotting time of such prepa- 
rations was not appreciably affected by the addition of either native dextran 
or E.  coli  endotoxin,  and it would thus  appear  that  the phenomenon under 
study is an indirect effect of antigen-antibody interaction, mediated by plate- 
lets and perhaps related to the platelet-clumping effect described earlier  (2, 4). 
DISCUSSION 
In view of the extensive research activity in the fields of immunology and 
blood  coagulation,  it  seems  remarkable  that  the  coagulation-accelerating 
effect of antigen-antibody  reactions  has not been previously described.  The 
phenomenon seems to be a general  one, as it can be demonstrated in systems 
involving  protein  and  polysaccharide  antigens  and  with  natural  antibodies 
as well as those produced by active immunization.  It may also have consider- 
able  significance,  bearing  as  it  may  on  the  pathogenesis  of  tissue  damage 
produced  by in  vivo antigen-antibody  interaction.  The  phenomenon  would 
furthermore appear to offer a  new and sensitive method for the detection of 
antigen-antibody interaction  in vitro,  and experiments have been undertaken 
to  determine  its  possible  usefulness  in  the  demonstration  of  antibodies  in 
transplantation  immunity,  autoallergic  disorders,  and other systems in which 
conventional methods of antibody detection have sometimes yielded equivocal 
results.  It  will  also  be  of  interest  to  determine  whether  non-precipitating 
antigen-antibody  systems  produce  this  effect  and  whether  complement  is 
involved, although the testing of this latter point may be difficult  in view of 
the  requirement  for fresh whole blood in  the  test  system  and  of  the  anti- 
coagulant effect of many anticomplementary substances. 
It  has  not yet been possible to  devise experiments  to determine  whether 
antigen-antibody  interaction  is  capable  of actually  initiating  coagulation  or 
whether the effect is limited to an acceleration of the clotting process, once this 
has  begun,  nor  has  it  been  determined  whether  the  phenomenon  occurs in 
~vo. If the effect is mediated, as it seems to be, by platelets and is related to 
the platelet-clumping  phenomenon  (2,  4),  then  in  vivo studies  should prove 
useful since the occurrence  of intravascular platelet clumping  during antigen- 
antibody reactions is readily demonstrable (10). 
If actual initiation of coagulation can be demonstrated, an interesting pos- 
sibility will, of course,  be raised concerning  the mechanism  of  physiological 
coagulation  initiation.  Thromboplastinogen,  in  tissue  extracts  or  platelets, 
may contain  antigenic  material  which  reacts  with  natural  antibody  just as .]'.  ROBBINS  AND  C.  A.  STETSON 
horse liver glycogen reacts with natural antibody in horse blood (5). The normal 
initiation of coagulation might  be  a  consequence of the  interaction of  this 
antigen-antibody system, with generation of thromboplastin and subsequent 
involvement of the other components of the clotting mechanism. It is difficult 
to square  this hypothesis with the observation that patients with agamma- 
globulinemia apparently possess normal coagulation mechanisms (11)  unless 
the  term  "natural  antibody"  is  broadened  to  include  properdin,  which  is 
present in normal concentrations in these patients (12). 
At present,  it seems desirable to identify the mechanism directly affected 
by antigen-antibody interaction, so that some more suitable indicator system 
can  be  developed or utilized. The  technique described  for determination of 
coagulation time does not lend itself well to quantitative studies, because of 
the lack of a sharp end-point and because of the variable prolongation of the 
coagulation time obtained in control preparations in successive experiments. 
A better assay method would permit a more critical approach to some of the 
problems outlined, and experiments to that end are now in progress. 
SUMMARY 
Each of several antigen-antibody systems studied has been found to affect 
the coagulation mechanism in the rabbit, causing a marked shortening of the 
coagulation time in vitro of samples of whole blood maintained in siliconized 
glassware.  Addition of specific  antigen to  the  blood of actively immunized 
animals or addition of antigen-antibody mixtures to the blood of normal ani- 
mals produced the effect. The coagulation time of plasma  was not affected, 
indicating that the phenomenon may be mediated by an effect on platelets. 
This effect of antigen-antibody interaction may be involved in the production 
of tissue damage in vivo. 
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